- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04826315
Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention
January 4, 2022 updated by: Duke University
A Patient-Caregiver Behavioral Intervention for Older Adults With Cancer and Mild Cognitive Impairment
The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of the dyad has cancer and mild memory difficulties and/or concerns.
Participant and their spouse or participant and their family caregiver will have six, 60-minute video-conference sessions which will be scheduled at their convenience.
The investigator will loan participants a tablet computer (iPad) to use for videoconferencing and train the participant in its use.
Participant and their spouse or participant and their family caregiver will complete three assessments - one before starting the sessions, one after the sixth session, and one after 1 month.
Each assessment will include surveys, which the participant will complete separately from their spouse or family caregiver.
For most people, it will take upwards of 2 - 4 months to complete this study.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patient inclusion criteria include:
- Patients with Stage I-IV breast, colon, rectal, or lung cancer (newly diagnosed within 6 months; age 65 or older.
- Participants must be living at home (either in her/his own home).
- Participants must be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions.
- Exhibit Mild Cognitive Impairment.
- Have an informal family caregiver.
Inclusion Criteria:
(Partner or family member) inclusion criteria include:
- Caregivers are 18 older.
- Be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions.
- Either co-reside with the patient or spend at least 3-4 hours day caregiving.
- Not exhibit cognitive impairment.
Exclusion Criteria for both patients and caregivers:
- Participant has visual or hearing impairments that preclude participation.
- Participant has dementia and do not have the capacity to participate.
- Have a serious untreated psychiatric illness as documented in medical chart review.
- The patient and the caregiver score less than a 3 on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) on a scale 0 to 10 to screen for distress.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient Caregiver Dyad
Participants who are 65 years or older with cancer and mild cognitive impairment with their caregiver.
|
Six sixty minute sessions that teaches participants distress and communication coping skills.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of completed sessions as measured by enrollment log
Time Frame: Up to 10 weeks
|
Up to 10 weeks
|
|
|
Number of participants who are satisfied with the intervention as measured by a score of 24 or greater on the CSQ-8
Time Frame: Up to 10 weeks.
|
The Client Satisfaction Questionnaire (CSQ-8) is a self report measure of satisfaction with health and behavioral services received.
The CSQ-8 is measured on a four point Likert scale from 1 "Quite Dissatisfied" to 4 "Very Satisfied."
Scores range from 8-32, with higher values indicating higher satisfaction.
|
Up to 10 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Distress as measured by the DASS-21
Time Frame: Up to 10 weeks.
|
The Depression, Anxiety, and Stress Scale (DASS-21) measure will be used for rating general distress across three emotional states of depression, anxiety, and stress.
The measure has a total of 21 items.
Scores range from 0- 63, with higher scores indicating greater distress.
|
Up to 10 weeks.
|
|
Change in Quality of Life as measured by the FACT-G
Time Frame: Up to 10 weeks.
|
The Functional Assessment of Cancer Therapy: General (FACT-G) measure will be used for rating quality of life.
The measure has a total of 27 items.
Scores range from 0-108, with higher scores indicating greater quality of life.
|
Up to 10 weeks.
|
|
Change in Communication Patterns as measured by the CPQ-SF
Time Frame: Up to 10 weeks.
|
The Communication Patterns Questionnaire Short-Form (CPQ-SF) will be used for rating communication patterns in a relationship.
The measure has a total of 11 items.
Scores range from 11-99, higher scores indicate a greater likelihood of using a particular communication pattern during conflict interactions.
|
Up to 10 weeks.
|
|
Change in Relationship Satisfaction as measured by the Mutuality Scale of the Family Care Inventory
Time Frame: Up to 10 weeks.
|
The Mutuality Scale of the Family Care Inventory will be used for rating mutual concerns and overall relationship satisfaction.
The measure consists of 15 items.
Scores range from 0-60, higher scores indicate greater relationship satisfaction.
|
Up to 10 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 15, 2022
Primary Completion (Anticipated)
November 30, 2026
Study Completion (Anticipated)
November 30, 2026
Study Registration Dates
First Submitted
March 29, 2021
First Submitted That Met QC Criteria
March 29, 2021
First Posted (Actual)
April 1, 2021
Study Record Updates
Last Update Posted (Actual)
January 19, 2022
Last Update Submitted That Met QC Criteria
January 4, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00107680
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on COPE +
-
Duke UniversityNational Cancer Institute (NCI)CompletedAdvanced CancerUnited States
-
Ohio State UniversityUniversity of South Florida; New York University; National Institute on Minority... and other collaboratorsCompletedDepression | Anxiety | Emotional Disturbances | Nutritional Deficiency | Pregnancy Late | Post-Partum DepressionUnited States
-
National Taiwan University HospitalRecruitingEducation, MedicalTaiwan
-
Ohio State UniversityAmerican Foundation for Suicide Prevention; University of San DiegoCompletedDepression | Burnout, Professional | Suicide ThreatUnited States
-
University of South FloridaRecruitingOppositional Defiant Disorder | Insomnia ChronicUnited States
-
Duke UniversityRecruitingCancer | Cognitive ImpairmentUnited States
-
Universidad Nacional de Educación a DistanciaIES Isaac NewtonCompletedDepressive Symptoms | Parental Stress | Anxiety SymptomsSpain
-
Florida International UniversityCompleted
-
Ohio State UniversityAmerican Nurses Foundation; Sigma Theta Tau International Honor Society of... and other collaboratorsCompletedChildhood Asthma | Childhood Anxiety Disorder | Childhood DepressionUnited States
-
Vastra Gotaland RegionGöteborg UniversityCompleted